Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Net-Interest-Income" stands at -0.062 Billion Japanese Yens for the trailing twelve months (TTM) period ending 12/31/2024, the highest value since 09/30/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.055 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 0.055 Billion Japanese Yens.
The 3 year change is -2.61 Billion Japanese Yens.
The 5 year change is -3.18 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Interest Income | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Interest Income | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Interest Income | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Interest Income | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Interest Income | 280,205,508,085.11 |